Pacira Q3 Earnings Top, Revenues Miss Despite Exparel Sales Growth

Pacira BioSciences, Inc. (PCRX) reported third-quarter 2024 adjusted earnings of 79 cents per share, which beat the Zacks Consensus Estimate of 72 cents. The company had reported adjusted earnings of 72 cents per share in the year-ago quarter.Total revenues amounted to $168.6 million, which increased 3% year over year but missed the Zacks Consensus Estimate of $169 million.PCRX’s Q3 Results in DetailPacira’s top line comprises product sales and royalty revenues. The company recognizes product revenues from ...